About cataract surgery devices
Cataract surgery is a procedure to remove the clouded natural lens, that is due to cataract, from the eye and replace it with an artificial lens that restores vision. Only surgical removal of cataract can restore vision.
Technavio’s analysts forecast the Global cataract surgery devices market to grow at a CAGR of 3.42% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the cataract surgery devices market. To calculate the market size, the report considers the revenue generated from end-users such as hospitals, ophthalmology clinics, and ASCs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global cataract surgery devices market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Carl Zeiss Meditec
• HOYA
• Johnson & Johnson
• NIDEK
• Novartis
• Valeant Pharmaceuticals
Market driver
• increasing prevalence of cataract and rise in geriatric population
• For a full, detailed list, view our report
Market challenge
• High cost of cataract surgeries and insufficient insurance coverage
• For a full, detailed list, view our report
Market trend
• Increasing medical tourism for low cost cataract surgery
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• IOLs
• Phacoemulsification devices
• OVDs
• Femtosecond lasers
• Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Hospitals
• Ophthalmology clinics
• ASCs
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Cataract surgery devices market in Americas
• Cataract surgery devices market in EMEA
• Cataract surgery devices market in APAC
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Increasing medical tourism for low cost cataract surgery
• Increasing access to cataract surgery in emerging markets
• Increasing strategic collaborations and M&A
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive landscape
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Carl Zeiss Meditec
• HOYA
• Johnson & Johnson
• NIDEK
• Novartis
• Valeant Pharmaceuticals
PART 16: APPENDIX
• List of abbreviations
?
?
Exhibit 01: Global ophthalmology devices market
Exhibit 02: Global ophthalmology devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Global cataract surgery devices market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global cataract surgery devices market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global cataract surgery devices market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global cataract surgery devices market share by product – 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global IOLs market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global IOLs market – Year-over-year growth 2018-2022 (%)
Exhibit 22: Global phacoemulsification devices market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global phacoemulsification devices market – Year-over-year growth 2018-2022 (%)
Exhibit 24: Global OVDs market – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Global OVDs market – Year-over-year growth 2018-2022 (%)
Exhibit 26: Global femtosecond lasers market – Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Global femtosecond lasers market – Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Global cataract surgery devices market share by end-user (%) in 2017
Exhibit 31: Global cataract surgery devices market– Market share by geography 2017-2022 (%)
Exhibit 32: Regional comparison
Exhibit 33: Cataract surgery devices market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: Cataract surgery devices market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in Americas
Exhibit 36: Cataract surgery devices market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 37: Cataract surgery devices market EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in EMEA
Exhibit 39: Cataract surgery devices market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 40: Cataract surgery devices market in APAC – Year-over-year growth 2018-2022 (%)
Exhibit 41: Top 3 countries in APAC
Exhibit 42: Market opportunity
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Carl Zeiss Meditec – Overview
Exhibit 49: Carl Zeiss Meditec – Business segments
Exhibit 50: Carl Zeiss Meditec – Organizational developments
Exhibit 51: Carl Zeiss Meditec – Geographic focus
Exhibit 52: Carl Zeiss Meditec – Segment focus
Exhibit 53: Carl Zeiss Meditec – Key offerings
Exhibit 54: Carl Zeiss Meditec – Key customers
Exhibit 55: HOYA – Overview
Exhibit 56: HOYA – Business segments
Exhibit 57: HOYA – Organizational developments
Exhibit 58: HOYA – Geographic focus
Exhibit 59: HOYA – Segment focus
Exhibit 60: HOYA – Key offerings
Exhibit 61: HOYA – Key customers
Exhibit 62: Johnson & Johnson – Overview
Exhibit 63: Johnson & Johnson – Business segments
Exhibit 64: Johnson & Johnson – Organizational developments
Exhibit 65: Johnson & Johnson – Geographic focus
Exhibit 66: Johnson & Johnson – Segment focus
Exhibit 67: Johnson & Johnson – Key offerings
Exhibit 68: Johnson & Johnson – Key customers
Exhibit 69: NIDEK – Overview
Exhibit 70: NIDEK – Business segments
Exhibit 71: NIDEK – Organizational developments
Exhibit 72: NIDEK – Geographic focus
Exhibit 73: NIDEK – Segment focus
Exhibit 74: NIDEK – Key offerings
Exhibit 75: NIDEK – Key customers
Exhibit 76: Novartis – Overview
Exhibit 77: Novartis – Business segments
Exhibit 78: Novartis – Organizational developments
Exhibit 79: Novartis – Geographic focus
Exhibit 80: Novartis – Segment focus
Exhibit 81: Novartis – Key offerings
Exhibit 82: Novartis – Key customers
Exhibit 83: Valeant Pharmaceuticals – Overview
Exhibit 84: Valeant Pharmaceuticals – Business segments
Exhibit 85: Valeant Pharmaceuticals – Organizational developments
Exhibit 86: Valeant Pharmaceuticals – Geographic focus
Exhibit 87: Valeant Pharmaceuticals – Segment focus
Exhibit 88: Valeant Pharmaceuticals – Key offerings
Exhibit 89: Valeant Pharmaceuticals – Key customers
